Scientists identify antibodies that neutralize Omicron
Scientists have identified antibodies that could target unchanged parts of the new coronavirus as it continues to change and evolve, a breakthrough that could lead to new therapies to neutralize Omicron and other variants of Covid-19.
Identifying such "neutralizing" antibodies in the coronavirus spike protein, which the virus uses to enter human cells, could help develop the best vaccines and antibodies that will be effective not only against Omicron, but even against other variants that may appear in the future, he said. David Veesler from the University of Washington School of Medicine in the USA.
"This finding tells us that by focusing on antibodies targeting these highly conserved sites in yeast protein, there is a way to overcome the ongoing evolution of the virus," Dr Veesler said in a statement.